New York University
Dr Jeremy R Beitler is an Associate Professor of Medicine at New York University and Director of the Acute Respiratory Failure and Sepsis Precision Interventions (ASPIRE) Trials Program. He is a practicing intensivist and clinical trialist with expertise in strategies to individualize respiratory support in patients with acute respiratory failure.
Minimizing Lung Stress to Improve Survival in Acute Respiratory Distress Syndrome
Sunday, March 22, 2026
12:15 PM - 1:15 PM Central Time
Disclosure(s): Calcimedica: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Mezzion: Consultant (Terminated, January 4, 2024); Regeneron: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Sedana Medical: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing)
CD163 May Predict Lung Injury and Outcomes in Acute Respiratory Distress Syndrome
Sunday, March 22, 2026
12:15 PM - 1:15 PM Central Time
Disclosure(s): Calcimedica: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Mezzion: Consultant (Terminated, January 4, 2024); Regeneron: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Sedana Medical: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing)
Association Between Angiopoietin-2 and Multiorgan Dysfunction in ARDS Over Time
Sunday, March 22, 2026
2:45 PM - 3:45 PM Central Time
Disclosure(s): Calcimedica: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Mezzion: Consultant (Terminated, January 4, 2024); Regeneron: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Sedana Medical: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing)
Influence of Angiopoietin-2 on Sedation Depth in Patients With Acute Respiratory Distress Syndrome
Sunday, March 22, 2026
2:45 PM - 3:45 PM Central Time
Disclosure(s): Calcimedica: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Mezzion: Consultant (Terminated, January 4, 2024); Regeneron: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Sedana Medical: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing)
Oxygenation Index Tracks Clinical Outcomes and Biomarkers Better Than PaO2/FiO2 in Adults With ARDS
Monday, March 23, 2026
10:10 AM - 11:10 AM Central Time
Disclosure(s): Calcimedica: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Mezzion: Consultant (Terminated, January 4, 2024); Regeneron: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Sedana Medical: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing)
High Driving Pressures Are Associated With Lung Injury Biomarkers and Outcomes in ARDS
Monday, March 23, 2026
2:30 PM - 3:30 PM Central Time
Disclosure(s): Calcimedica: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Mezzion: Consultant (Terminated, January 4, 2024); Regeneron: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Sedana Medical: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing)
